Arrowhead Pharmaceuticals, Inc.
- Sector
- Healthcare
- Industry
- Biotechnology
- ISIN
- US04280A1007
- CUSIP
- 04280A100
ARWRPrice Chart
Click Calculate to get results
ARWRPerformance
The chart shows the growth of $10,000 invested in Arrowhead Pharmaceuticals, Inc. on Jan 5, 2010 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $126,611 for a total return of roughly 1,166.11%. All prices are adjusted for splits and dividends.
ARWRReturns in periods
| Period | Return |
|---|---|
| 1M | -23.03% |
| 6M | -14.56% |
| YTD | -10.90% |
| 1Y | 40.68% |
| 5Y | 64.72% |
| 10Y | 29.44% |
ARWRMonthly Returns Heatmap
Click Calculate to get results
ARWRDividends
ARWR doesn't pay dividends
ARWRDrawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
ARWRWorst Drawdowns
The table below shows the maximum drawdowns of the Arrowhead Pharmaceuticals, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.
The maximum drawdown since January 2010 for the Arrowhead Pharmaceuticals, Inc. is 95.33%, recorded on Dec 16, 2016. It took 619 trading sessions for the portfolio to recover.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -95.33% | Mar 11, 2014 | 701 | Dec 16, 2016 | 619 | Jun 6, 2019 | 1320 |
| -90.86% | Jun 7, 2010 | 726 | Apr 24, 2013 | 202 | Feb 11, 2014 | 928 |
| -71.84% | Dec 2, 2019 | 74 | Mar 18, 2020 | 186 | Dec 10, 2020 | 260 |
| -32.19% | Feb 8, 2021 | 35 | Mar 29, 2021 | — | — | — |
| -27.19% | Mar 24, 2010 | 3 | Mar 26, 2010 | 2 | Mar 30, 2010 | 5 |
| -25% | Jan 26, 2010 | 24 | Mar 1, 2010 | 15 | Mar 22, 2010 | 39 |
| -22.66% | Aug 30, 2019 | 20 | Sep 27, 2019 | 14 | Oct 17, 2019 | 34 |
| -19.35% | Apr 30, 2010 | 5 | May 6, 2010 | 19 | Jun 3, 2010 | 24 |
| -14.92% | Dec 24, 2020 | 7 | Jan 5, 2021 | 22 | Feb 5, 2021 | 29 |
| -13.41% | Feb 24, 2014 | 5 | Feb 28, 2014 | 3 | Mar 5, 2014 | 8 |
ARWRVolatility Chart
Current Arrowhead Pharmaceuticals, Inc. volatility is 34.93%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.
Portfolios with Arrowhead Pharmaceuticals, Inc.
Loading data...